Metsera, Inc. (NASDAQ:MTSR - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $29.16, but opened at $28.00. Metsera shares last traded at $28.04, with a volume of 95,958 shares trading hands.
Wall Street Analysts Forecast Growth
MTSR has been the topic of a number of research analyst reports. Bank of America initiated coverage on shares of Metsera in a report on Tuesday, February 25th. They issued a "buy" rating and a $38.00 price target on the stock. Cantor Fitzgerald started coverage on Metsera in a research note on Tuesday, February 25th. They set an "overweight" rating for the company. Guggenheim began coverage on Metsera in a research report on Tuesday, February 25th. They set a "buy" rating and a $56.00 price objective on the stock. Finally, Evercore ISI started coverage on Metsera in a research note on Tuesday, February 25th. They issued an "outperform" rating for the company.
Get Our Latest Analysis on MTSR
Metsera Price Performance
Metsera (NASDAQ:MTSR - Get Free Report) last issued its quarterly earnings data on Wednesday, March 26th. The company reported ($3.52) EPS for the quarter.
About Metsera
(
Get Free Report)
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
Featured Articles
Before you consider Metsera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Metsera wasn't on the list.
While Metsera currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
